{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:57:44Z","timestamp":1772135864643,"version":"3.50.1"},"reference-count":162,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.phrs.2004.02.004","type":"journal-article","created":{"date-parts":[[2004,4,10]],"date-time":"2004-04-10T10:53:02Z","timestamp":1081594382000},"page":"453-469","source":"Crossref","is-referenced-by-count":36,"title":["Emerging aspects of pharmacotherapy for obesity and metabolic syndrome"],"prefix":"10.1016","volume":"50","author":[{"given":"Enzo","family":"Nisoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele O.","family":"Carruba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2004.02.004_BIB1","unstructured":"World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation Technical Report Series 894, Geneva, Switzerland; 2000."},{"issue":"Suppl. 4","key":"10.1016\/j.phrs.2004.02.004_BIB2","doi-asserted-by":"crossref","first-page":"239S","DOI":"10.1038\/oby.2001.125","article-title":"Childhood obesity: the health issue","volume":"9","author":"Deckelbaum","year":"2001","journal-title":"Obes. Res"},{"key":"10.1016\/j.phrs.2004.02.004_BIB3","unstructured":"U.S. Department of Health and Human Services. The Surgeon General\u2019s call to action to prevent and decrease overweight and obesity 2001. U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General, Rockville, MD; 2001."},{"key":"10.1016\/j.phrs.2004.02.004_BIB4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00006","article-title":"Medical hazards of obesity","volume":"119","author":"Pi-Sunyer","year":"1993","journal-title":"Ann. Int. Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB5","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199509143331101","article-title":"Body weight and mortality among women","volume":"333","author":"Manson","year":"1995","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2337\/diab.41.6.715","article-title":"Prospective analysis of the insulin-resistance syndrome (syndrome X)","volume":"41","author":"Haffner","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2004.02.004_BIB8","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/diacare.24.4.683","article-title":"Cardiovascular morbidity and mortality associated with the metabolic syndrome","volume":"24","author":"Isomaa","year":"2001","journal-title":"Diab. Care"},{"key":"10.1016\/j.phrs.2004.02.004_BIB9","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/oxfordjournals.aje.a009572","article-title":"Syndrome X and mortality: a population-based study","volume":"148","author":"Trevisan","year":"1998","journal-title":"Am. J. Epidemiol"},{"key":"10.1016\/j.phrs.2004.02.004_BIB10","doi-asserted-by":"crossref","unstructured":"National Institutes of Health. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). NIH Publication 01-3670. Bethesda, MD: National Institutes of Health; 2001.","DOI":"10.1001\/jama.285.19.2486"},{"key":"10.1016\/j.phrs.2004.02.004_BIB11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2004.02.004_BIB12","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/oxfordjournals.aje.a117386","article-title":"Prospective study of intentional weight loss and mortality in never-smoking US white women aged 40\u201364 years","volume":"141","author":"Williamson","year":"1995","journal-title":"Am. J. Epidemiol"},{"key":"10.1016\/j.phrs.2004.02.004_BIB13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.7326\/0003-4819-138-5-200303040-00007","article-title":"Intentional weight loss and death in overweight and obese U.S. adults 35 years of age and older","volume":"138","author":"Gregg","year":"2003","journal-title":"Ann. Intern. Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB14","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1126\/science.280.5368.1371","article-title":"Environmental contributions to the obesity epidemic","volume":"280","author":"Hill","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.phrs.2004.02.004_BIB15","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1126\/science.280.5368.1378","article-title":"Signals that regulate food intake and energy homeostasis","volume":"280","author":"Woods","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.phrs.2004.02.004_BIB16","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0029-6465(22)02695-0","article-title":"Pharmaceutical treatment of obesity","volume":"32","author":"Blackburn","year":"1997","journal-title":"Nurs. Clin. North Am"},{"key":"10.1016\/j.phrs.2004.02.004_BIB17","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJM198104163041602","article-title":"The effect of weight reduction on blood pressure","volume":"304","author":"Tuck","year":"1981","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/ajcn\/56.2.320","article-title":"Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis","volume":"56","author":"Dattilo","year":"1992","journal-title":"Am. J. Clin. Nutr"},{"key":"10.1016\/j.phrs.2004.02.004_BIB19","doi-asserted-by":"crossref","unstructured":"UK prospective study on maturity onset diabetes. Effect of diet and sulphonylurea, insulin or biguainide therapy on fasting plasma glucose and body weight over a year. A multicentre study. Diabetologia 1983;24:404\u201311.","DOI":"10.1007\/BF00257337"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2004.02.004_BIB20","first-page":"S10","article-title":"The benefits of modest weight loss in type 2 diabetes","volume":"21","author":"Bosello","year":"1997","journal-title":"Int. J. Obes. Relat. Metab. Disord"},{"key":"10.1016\/j.phrs.2004.02.004_BIB21","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"for the Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB22","unstructured":"U.S. Department of Health and Human Services. Diet and exercise dramatically delay type 2 diabetes: diabetes medication metformin also effective. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Available at: http:\/\/www.niddk.nih.gov\/welcome\/release\/8_9_01.htm. Accessed March 12, 2002."},{"key":"10.1016\/j.phrs.2004.02.004_BIB23","doi-asserted-by":"crossref","unstructured":"National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity. JAMA 1996;276:1907\u201315.","DOI":"10.1001\/jama.1996.03540230057036"},{"key":"10.1016\/j.phrs.2004.02.004_BIB24","unstructured":"National Heart, Lung, and Blood Institute Obesity Education Initiative. The practical guide identification, evaluation, and treatment of overweight and obesity in adults. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute, Rockville, MD. NIH Publication Number 00-4084; October 2000."},{"key":"10.1016\/j.phrs.2004.02.004_BIB25","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199608293350910","article-title":"Pharmacotherapy for obesity\u2014do the benefits outweigh the risks","volume":"335","author":"Manson","year":"1996","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB26","unstructured":"Royal College of Physicians of London. Clinical management of overweight and obese patients with particular reference to the use of drugs. A report of the Royal College of Physicians of London, London; December 1998."},{"key":"10.1016\/j.phrs.2004.02.004_BIB27","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2165\/00003495-199243060-00003","article-title":"Appetite suppressants. A review","volume":"43","author":"Silverstone","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.phrs.2004.02.004_BIB28","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1056\/NEJM200012213432501","article-title":"Phenylpropanolamine and the risk of hemorrhagic stroke","volume":"343","author":"Kernan","year":"2000","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB29","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1001\/jama.283.13.1703","article-title":"Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine\/fenfluramine","volume":"283","author":"Gardin","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2004.02.004_BIB30","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/2164","article-title":"Unraveling the central nervous system pathways underlying responses to leptin","volume":"1","author":"Elmquist","year":"1998","journal-title":"Nat. Neurosci"},{"key":"10.1016\/j.phrs.2004.02.004_BIB32","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1074\/jbc.272.10.6093","article-title":"The leptin receptor","volume":"272","author":"Tartaglia","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.phrs.2004.02.004_BIB33","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/geno.1997.4962","article-title":"Fine structure of the murine leptin receptor gene: splice site suppression is required to form two alternatively spliced transcripts","volume":"45","author":"Chua","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.phrs.2004.02.004_BIB34","doi-asserted-by":"crossref","first-page":"45898","DOI":"10.1074\/jbc.M205825200","article-title":"Generation of soluble leptin receptor by ectodomain shedding of membrane-spanning receptors in vitro and in vivo","volume":"277","author":"Ge","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.phrs.2004.02.004_BIB35","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1172\/JCI9842","article-title":"Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity","volume":"105","author":"El Haschimi","year":"2000","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2004.02.004_BIB36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0196-9781(96)00025-3","article-title":"Leptin enters the brain by a saturable system independent of insulin","volume":"17","author":"Banks","year":"1996","journal-title":"Peptides"},{"key":"10.1016\/j.phrs.2004.02.004_BIB37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0896-6273(00)81084-3","article-title":"From lesions to leptin: hypothalamic control of food intake and body weight","volume":"22","author":"Elmquist","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2004.02.004_BIB38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/(SICI)1096-9861(19980615)395:4<535::AID-CNE9>3.0.CO;2-2","article-title":"Distributions of leptin receptor mRNA isoforms in the rat brain","volume":"395","author":"Elmquist","year":"1998","journal-title":"J. Comp. Neurol"},{"key":"10.1016\/j.phrs.2004.02.004_BIB39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/002215549904700309","article-title":"Leptin receptor long-form splice-variant protein expression in neuron cell bodies of the brain and co-localization with neuropeptide Y mRNA in the arcuate nucleus","volume":"47","author":"Baskin","year":"1999","journal-title":"J. Histochem. Cytochem"},{"key":"10.1016\/j.phrs.2004.02.004_BIB40","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","author":"Schwartz","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB41","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/35078085","article-title":"Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus","volume":"411","author":"Cowley","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/385165a0","article-title":"Role of melanocortinergic neurons in feeding and the agouti obesity syndrome","volume":"385","author":"Fan","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/37016","article-title":"Melanocortin receptors in leptin effects","volume":"390","author":"Seeley","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB44","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.274.5293.1704","article-title":"Attenuation of the obesity syndrome of ob\/ob mice by the loss of neuropeptide Y","volume":"274","author":"Erickson","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.phrs.2004.02.004_BIB45","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nature01388","article-title":"STAT3 signaling is required for leptin regulation of energy balance but not reproduction","volume":"421","author":"Bates","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB46","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/43185","article-title":"Congenital leptin deficiency is associated with severe early-onset obesity in humans","volume":"387","author":"Montague","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ng0398-213","article-title":"A leptin missense mutation associated with hypogonadism and morbid obesity","volume":"18","author":"Strobel","year":"1998","journal-title":"Nature Genet"},{"key":"10.1016\/j.phrs.2004.02.004_BIB48","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB49","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM199909163411204","article-title":"Effects of recombinant leptin therapy in a child with congenital leptin deficiency","volume":"341","author":"Farooqi","year":"1999","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB50","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.7624777","article-title":"Weight-reducing effects of the plasma protein encoded by the obese gene","volume":"269","author":"Halaas","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.phrs.2004.02.004_BIB51","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.282.16.1568","article-title":"Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial","volume":"282","author":"Heymsfield","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2004.02.004_BIB52","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0140-6736(96)03173-X","article-title":"Decreased cerebrospinal-fluid\/serum leptin ratio in obesity: a possible mechanism for leptin resistance","volume":"348","author":"Caro","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2004.02.004_BIB53","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/35102112","article-title":"Metabolism: partial leptin deficiency and human adiposity","volume":"414","author":"Farooqi","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0031-6865(99)00050-3","article-title":"The ciliary neurotrophic factor and its receptor, CNTFR","volume":"74","author":"Sleeman","year":"2000","journal-title":"Pharm. Acta Helv"},{"key":"10.1016\/j.phrs.2004.02.004_BIB55","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1073\/pnas.061034298","article-title":"Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity","volume":"98","author":"Lambert","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.phrs.2004.02.004_BIB56","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","article-title":"Role of brain insulin receptor in control of body weight and reproduction","volume":"289","author":"Bruning","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.phrs.2004.02.004_BIB57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-131-4-199908170-00008","article-title":"Pharmacological therapy for type 2 diabetes","volume":"17","author":"DeFronzo","year":"1999","journal-title":"Ann. Intern. Med"},{"issue":"2","key":"10.1016\/j.phrs.2004.02.004_BIB58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm0202-179","article-title":"Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity","volume":"8","author":"Air","year":"2002","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB59","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.284.5416.974","article-title":"Discovery of a small molecule insulin mimetic with antidiabetic activity in mice","volume":"284","author":"Zhang","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.phrs.2004.02.004_BIB60","doi-asserted-by":"crossref","first-page":"36590","DOI":"10.1074\/jbc.M006287200","article-title":"Activation of insulin signal transduction pathway and anti-diabetic activity of small molecule insulin receptor activators","volume":"275","author":"Qureshi","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.phrs.2004.02.004_BIB61","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2337\/diab.44.2.147","article-title":"Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression","volume":"44","author":"Sipols","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2004.02.004_BIB62","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1043-2760(99)00153-8","article-title":"The central melanocortin system and energy homeostasis","volume":"10","author":"Cone","year":"1999","journal-title":"Trends Endocrinol. Metab"},{"key":"10.1016\/j.phrs.2004.02.004_BIB63","first-page":"1298","article-title":"Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain","volume":"8","author":"Mountjoy","year":"1994","journal-title":"Mol. Endocrinol"},{"key":"10.1016\/j.phrs.2004.02.004_BIB64","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0092-8674(00)81865-6","article-title":"Targeted disruption of the melanocortin-4 receptor results in obesity in mice","volume":"88","author":"Huszar","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2004.02.004_BIB65","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/2407","article-title":"A frameshift mutation in human MC4R is associated with a dominant form of obesity","volume":"20","author":"Vaisse","year":"1998","journal-title":"Nature Genet"},{"issue":"12","key":"10.1016\/j.phrs.2004.02.004_BIB66","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa021971","article-title":"Binge eating as a major phenotype of melanocortin 4 receptor gene mutations","volume":"348","author":"Branson","year":"2003","journal-title":"N. Engl. J. Med"},{"issue":"12","key":"10.1016\/j.phrs.2004.02.004_BIB67","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa022050","article-title":"Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene","volume":"348","author":"Farooqi","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB68","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1101\/gad.11.5.593","article-title":"Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice","volume":"11","author":"Shutter","year":"1997","journal-title":"Genes Dev"},{"key":"10.1016\/j.phrs.2004.02.004_BIB69","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1126\/science.278.5335.135","article-title":"Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein","volume":"278","author":"Ollmann","year":"1997","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.phrs.2004.02.004_BIB70","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1152\/ajpregu.2000.279.1.R47","article-title":"Long-term orexigenic effects of AgRP-(83\u2013132) involve mechanisms other than melanocortin receptor blockade","volume":"279","author":"Hagan","year":"2000","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol"},{"issue":"7","key":"10.1016\/j.phrs.2004.02.004_BIB71","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1172\/JCI200112954","article-title":"Central melanocortin receptors regulate insulin action","volume":"108","author":"Obici","year":"2001","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2004.02.004_BIB72","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/0024-3205(84)90032-8","article-title":"Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus","volume":"35","author":"Stanley","year":"1984","journal-title":"Life Sci"},{"key":"10.1016\/j.phrs.2004.02.004_BIB73","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0169-328X(94)90377-8","article-title":"Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion","volume":"21","author":"Akabayashi","year":"1994","journal-title":"Brain Res. Mol. Brain Res"},{"key":"10.1016\/j.phrs.2004.02.004_BIB74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0006-8993(93)91727-A","article-title":"Injection of anti-neuropeptide Y-globulin into the hypothalamic paraventricular nucleus decreases food intake in rats","volume":"601","author":"Shibasaki","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.phrs.2004.02.004_BIB75","doi-asserted-by":"crossref","first-page":"15659","DOI":"10.1073\/pnas.95.26.15659","article-title":"Obesity and mild hyperinsulinemia found in neuropeptide Y Y1 receptor-deficient mice","volume":"95","author":"Kushi","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.phrs.2004.02.004_BIB76","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nm0698-722","article-title":"Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor","volume":"4","author":"Pedrazzini","year":"1998","journal-title":"Nature Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB77","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/13514","article-title":"Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor","volume":"5","author":"Naveilhan","year":"1999","journal-title":"Nature Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB78","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nm0698-718","article-title":"Role of the Y5 neuropeptide Y receptor in feeding and obesity","volume":"4","author":"Marsh","year":"1998","journal-title":"Nature Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB79","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/29993","article-title":"Hypothalamic CART is a new anorectic peptide regulated by leptin","volume":"393","author":"Kristensen","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB80","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1210\/endo.142.10.8416","article-title":"Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet","volume":"142","author":"Asnicar","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2004.02.004_BIB81","doi-asserted-by":"crossref","first-page":"R1862","DOI":"10.1152\/ajpregu.2001.281.6.R1862","article-title":"Intracerebroventricular CART peptide reduces food intake and alters motor behavior at a hindbrain site","volume":"281","author":"Aja","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol"},{"key":"10.1016\/j.phrs.2004.02.004_BIB82","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/endo.142.8.8304","article-title":"Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei","volume":"142","author":"Abbott","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2004.02.004_BIB83","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1126\/science.273.5281.1561","article-title":"Appetite-suppressing effects of urocortin, a CRF-related neuropeptide","volume":"273","author":"Spina","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.phrs.2004.02.004_BIB84","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/74255","article-title":"Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2","volume":"24","author":"Coste","year":"2000","journal-title":"Nature Genet"},{"key":"10.1016\/j.phrs.2004.02.004_BIB85","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1210\/endo.141.8.7606","article-title":"Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice","volume":"141","author":"Bradbury","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2004.02.004_BIB86","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1054\/npep.1999.0053","article-title":"Glucagon-like peptide-1 (7\u201336) amide: a central regulator of satiety and interoceptive stress","volume":"33","author":"Van Dijk","year":"1999","journal-title":"Neuropeptides"},{"key":"10.1016\/j.phrs.2004.02.004_BIB87","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1017\/S0029665100000422","article-title":"Afferent signals regulating food intake","volume":"59","author":"Bray","year":"2000","journal-title":"Proc. Nutr. Soc"},{"key":"10.1016\/j.phrs.2004.02.004_BIB88","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/nm1196-1254","article-title":"Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene","volume":"2","author":"Scrocchi","year":"1996","journal-title":"Nature Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB89","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm0102-75","article-title":"Interleukin-6-deficient mice develop mature-onset obesity","volume":"8","author":"Wallenius","year":"2002","journal-title":"Nature Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB90","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/emboj\/19.6.1290","article-title":"BDNF regulates eating behavior and locomotor activity in mice","volume":"19","author":"Kernie","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.phrs.2004.02.004_BIB91","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.bjp.0703617","article-title":"Characterization of the binding of [(125)I]-human prolactin releasing peptide (PrRP) to GPR10, a novel G protein coupled receptor","volume":"131","author":"Langmead","year":"2000","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.phrs.2004.02.004_BIB92","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/35017610","article-title":"Identification of receptors for neuromedin U and its role in feeding","volume":"406","author":"Howard","year":"2000","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.phrs.2004.02.004_BIB93","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1210\/jc.2003-030421","article-title":"Oxyntomodulin suppresses appetite and reduces food intake in humans","volume":"88","author":"Cohen","year":"2003","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.phrs.2004.02.004_BIB94","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/cne.903190204","article-title":"The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization","volume":"319","author":"Bittencourt","year":"1992","journal-title":"J. Comp. Neurol"},{"key":"10.1016\/j.phrs.2004.02.004_BIB95","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/380243a0","article-title":"A role for melanin-concentrating hormone in the central regulation of feeding behaviour","volume":"380","author":"Qu","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB96","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nm741","article-title":"Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor anatgonist","volume":"8","author":"Borosky","year":"2002","journal-title":"Nature Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB97","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB98","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35051587","article-title":"A role for ghrelin in the central regulation of feeding","volume":"409","author":"Nakazato","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB99","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/35038090","article-title":"Ghrelin induces adiposity in rodents","volume":"407","author":"Tschop","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB100","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/00365519609088805","article-title":"Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man","volume":"56","author":"Pedersen-Bjergaard","year":"1996","journal-title":"Scand. J. Clin. Lab. Invest"},{"key":"10.1016\/j.phrs.2004.02.004_BIB101","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nature00887","article-title":"Gut hormone PYY(3\u201336) physiologically inhibits food intake","volume":"418","author":"Batterham","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB102","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/35078085","article-title":"Leptin activates the anorexigenic POMC neurons through a neural network in the arcuate nucleus","volume":"411","author":"Cowley","year":"2001","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.phrs.2004.02.004_BIB103","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJMoa030204","article-title":"Inhibition of food intake in obese subjects by peptide YY3\u201336","volume":"349","author":"Batterham","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB104","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0091-6773(75)91684-3","article-title":"Cannabis: effects on hunger and thirst","volume":"15","author":"Abel","year":"1975","journal-title":"Behav. Biol"},{"key":"10.1016\/j.phrs.2004.02.004_BIB105","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0031-9384(98)00170-X","article-title":"Hyperphagia in pre-fed rats following oral delta9-THC","volume":"65","author":"Williams","year":"1998","journal-title":"Physiol. Behav"},{"key":"10.1016\/j.phrs.2004.02.004_BIB106","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0091-3057(01)00467-1","article-title":"Delta(9)-THC stimulates food intake in Lewis rats: effects on chow","volume":"68","author":"Koch","year":"2001","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.phrs.2004.02.004_BIB107","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130050953","article-title":"Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors","volume":"143","author":"Williams","year":"1999","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.phrs.2004.02.004_BIB108","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/sj.bjp.0704379","article-title":"Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats","volume":"134","author":"Jamshidi","year":"2001","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.phrs.2004.02.004_BIB109","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-2999(00)00059-5","article-title":"Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice","volume":"392","author":"Hao","year":"2000","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.phrs.2004.02.004_BIB110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev"},{"key":"10.1016\/j.phrs.2004.02.004_BIB111","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/35071214","article-title":"A hunger for cannabinoids","volume":"410","author":"Mechoulam","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB112","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.ijo.0802250","article-title":"The endogenous cannabinoid system as a modulator of food intake","volume":"27","author":"Cota","year":"2003","journal-title":"Int. J. Obes. Relat. Metab. Disord"},{"key":"10.1016\/j.phrs.2004.02.004_BIB113","first-page":"179","article-title":"SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset","volume":"9","author":"Simiand","year":"1998","journal-title":"Behav. Pharmacol"},{"key":"10.1016\/j.phrs.2004.02.004_BIB114","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35071088","article-title":"Leptin-regulated endocannabinoids are involved in maintaining food intake","volume":"410","author":"Di Marzo","year":"2001","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2004.02.004_BIB115","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1172\/JCI17725","article-title":"The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis","volume":"112","author":"Cota","year":"2003","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2004.02.004_BIB116","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1126\/science.288.5475.2379","article-title":"Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors","volume":"288","author":"Loftus","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.phrs.2004.02.004_BIB117","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1042\/bj3110595","article-title":"Multiple signalling pathways involved in the stimulation of fatty acid and glycogen synthesis by insulin in rat epididymal fat cells","volume":"311","author":"Moule","year":"1995","journal-title":"Biochem. J"},{"key":"10.1016\/j.phrs.2004.02.004_BIB118","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/35101657","article-title":"Intracellular signalling. Key enzyme in leptin-induced anorexia","volume":"413","author":"Niswender","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB119","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1042\/bj3330471","article-title":"Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling","volume":"333","author":"Shepherd","year":"1998","journal-title":"Biochem. J"},{"key":"10.1016\/j.phrs.2004.02.004_BIB120","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2337\/diabetes.48.9.1763","article-title":"Hypothalamic glucose sensor: similarities to and differences from pancreatic-cell mechanisms","volume":"48","author":"Yang","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2004.02.004_BIB121","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2337\/diabetes.51.2.271","article-title":"Central administration of oleic acid inhibits glucose production and food intake","volume":"51","author":"Obici","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2004.02.004_BIB122","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1073\/pnas.012606199","article-title":"Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides","volume":"99","author":"Shimokawa","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"6","key":"10.1016\/j.phrs.2004.02.004_BIB123","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nm873","article-title":"Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production","volume":"9","author":"Obici","year":"2003","journal-title":"Nature Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB124","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1074\/jbc.M211495200","article-title":"The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids","volume":"278","author":"Briscoe","year":"2003","journal-title":"J. Biol. Chem"},{"issue":"6860","key":"10.1016\/j.phrs.2004.02.004_BIB125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/35102582","article-title":"An anorexic lipid mediator regulated by feeding","volume":"414","author":"Rodriguez de Fonseca","year":"2001","journal-title":"Nature"},{"issue":"6953","key":"10.1016\/j.phrs.2004.02.004_BIB126","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","article-title":"Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-\u03b1","volume":"425","author":"Fu","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB127","first-page":"PL9, PL15","article-title":"Nitric oxide mediates hyperphagia of obese Zucker rats: relation to specific changes in the microstructure of feeding behavior","volume":"58","author":"Sticker-Krongrad","year":"1996","journal-title":"Life Sci"},{"key":"10.1016\/j.phrs.2004.02.004_BIB128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1469-7793.2000.00003.x","article-title":"Mitochondrial uncoupling proteins: from mitochondria to the regulation of energy balance","volume":"529","author":"Ricquier","year":"2000","journal-title":"J. Physiol"},{"key":"10.1016\/j.phrs.2004.02.004_BIB129","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0022-2275(20)37142-X","article-title":"Uncoupling protein gene: quantification of expression levels in adipose tissues of obese and non-obese humans","volume":"38","author":"Oberkofler","year":"1997","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.phrs.2004.02.004_BIB130","first-page":"E507","article-title":"Contribution of BAT and skeletal muscle to thermogenesis induced by ephedrine in man","volume":"248","author":"Astrup","year":"1985","journal-title":"Am. J. Physiol"},{"key":"10.1016\/j.phrs.2004.02.004_BIB131","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1467-789x.2000.00009.x","article-title":"The human uncoupling protein-1 gene (UCP1): present status and perspectives in obesity research","volume":"1","author":"Del Mar Gonzalez-Barroso","year":"2000","journal-title":"Obes. Rev"},{"key":"10.1016\/j.phrs.2004.02.004_BIB132","doi-asserted-by":"crossref","unstructured":"Nisoli E, Tonello C, Carruba MO. \u03b23-Adrenergic receptors: really relevant targets for anti-obesity drugs? Curr Med Chem Central Nerv Syst Agents 2003;3(3):257\u201373.","DOI":"10.2174\/1568015033477721"},{"key":"10.1016\/j.phrs.2004.02.004_BIB133","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1073160","article-title":"betaAR signaling required for diet-induced thermogenesis and obesity resistance","volume":"297","author":"Bachman","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.phrs.2004.02.004_BIB134","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0005-2728(00)00244-9","article-title":"Mitochondrial efficiency: lessons learned from transgenic mice","volume":"1504","author":"Harper","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2004.02.004_BIB135","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","article-title":"A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis","volume":"92","author":"Puigserver","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2004.02.004_BIB136","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","article-title":"Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1\u03b2","volume":"98","author":"Wu","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2004.02.004_BIB137","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/sj.ijo.0801106","article-title":"Cloning and mRNA tissue distribution of human PPAR coactivator-1","volume":"23","author":"Larrouy","year":"1999","journal-title":"Int. J. Obes. Relat. Metab. Disord"},{"key":"10.1016\/j.phrs.2004.02.004_BIB138","doi-asserted-by":"crossref","first-page":"33370","DOI":"10.1074\/jbc.M305235200","article-title":"Acquirement of brown fat cell features by human white adipocytes","volume":"278","author":"Tiraby","year":"2003","journal-title":"J. Biol. Chem"},{"issue":"5608","key":"10.1016\/j.phrs.2004.02.004_BIB139","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1126\/science.1079368","article-title":"Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide","volume":"299","author":"Nisoli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.phrs.2004.02.004_BIB140","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0092-8674(01)00474-3","article-title":"FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance","volume":"106","author":"Cederberg","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2004.02.004_BIB141","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nm1001-1128","article-title":"Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1","volume":"7","author":"Tsukiyama-Kohara","year":"2001","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2004.02.004_BIB142","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0031-9384(97)00518-0","article-title":"A beta-3 adrenergic agonist (BRL-37,344) decreases food intake","volume":"63","author":"Tsujii","year":"1998","journal-title":"Physiol. Behav"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2004.02.004_BIB143","first-page":"1","article-title":"Treatment of obesity with thermogenic beta-adrenoceptor agonists: studies on BRL 26830A in rodents","volume":"8","author":"Arch","year":"1984","journal-title":"Int. J. Obes"},{"key":"10.1016\/j.phrs.2004.02.004_BIB144","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(90)90034-A","article-title":"Effects of the beta 2-adrenoceptor agonist, clenbuterol, on muscle atrophy due to food deprivation in the rat","volume":"39","author":"Choo","year":"1990","journal-title":"Metabolism"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2004.02.004_BIB145","doi-asserted-by":"crossref","first-page":"S252","DOI":"10.1093\/ajcn\/55.1.252s","article-title":"BRL 35135, a potent and selective atypical beta-adrenoceptor agonist","volume":"55","author":"Cawthorne","year":"1992","journal-title":"Am. J. Clin. Nutr"},{"key":"10.1016\/j.phrs.2004.02.004_BIB146","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ddr.430320203","volume":"32","author":"Largis","year":"1994","journal-title":"Drug Dev. Res"},{"key":"10.1016\/j.phrs.2004.02.004_BIB147","doi-asserted-by":"crossref","unstructured":"Hansen BC. In: Lockwood D, Heffner TG, editors. Handbook of experimental pharmacology. Heidelberg: Springer-Verlag; 2000. p. 461\u201389.","DOI":"10.1007\/978-3-642-59651-3_18"},{"key":"10.1016\/j.phrs.2004.02.004_BIB148","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0960-894X(99)00316-9","article-title":"Prodrugs of CL316243: a selective beta3-adrenergic receptor agonist for treating obesity and diabetes","volume":"9","author":"Sum","year":"1999","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.phrs.2004.02.004_BIB149","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1042\/cs0860331","article-title":"Beta-adrenoceptor subtypes mediating the metabolic effects of BRL 35135 in man","volume":"86","author":"Wheeldon","year":"1994","journal-title":"Clin. Sci"},{"key":"10.1016\/j.phrs.2004.02.004_BIB150","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1172\/JCI2496","article-title":"A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys","volume":"101","author":"Fisher","year":"1998","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2004.02.004_BIB151","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1073\/pnas.0438006100","article-title":"Microtransplantation of membranes from cultured cells to Xenopus oocytes: a method to study neurotransmitter receptors embedded in native lipids","volume":"100","author":"Palma","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.phrs.2004.02.004_BIB152","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1098\/rspb.1982.0040","article-title":"Translation of exogenous messenger RNA coding for nicotinic acetylcholine receptors produces functional receptors in Xenopus oocytes","volume":"215","author":"Barnard","year":"1982","journal-title":"Proc. R. Soc. London Ser. B Biol. Sci"},{"key":"10.1016\/j.phrs.2004.02.004_BIB153","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/308421a0","article-title":"Messenger RNA from human brain induces drug- and voltage-operated channels in Xenopus oocytes","volume":"308","author":"Gundersen","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2004.02.004_BIB154","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nrd722","article-title":"Efficacy at G-protein-coupled receptors","volume":"1","author":"Kenakin","year":"2002","journal-title":"Nat. Rev. Drug Discov"},{"issue":"2","key":"10.1016\/j.phrs.2004.02.004_BIB155","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(03)00269-1","article-title":"Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity","volume":"113","author":"Wang","year":"2003","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.phrs.2004.02.004_BIB156","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1073\/pnas.091021198","article-title":"A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport","volume":"98","author":"Oliver","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"9","key":"10.1016\/j.phrs.2004.02.004_BIB157","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1021\/jm021080f","article-title":"Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1","volume":"46","author":"Ye","year":"2003","journal-title":"J. Med. Chem"},{"issue":"1","key":"10.1016\/j.phrs.2004.02.004_BIB158","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1677\/joe.0.1350045","article-title":"Relationship between the resting metabolic rate and hepatic metabolism in rats: effect of hyperthyroidism and fasting for 24 hours","volume":"135","author":"Iossa","year":"1992","journal-title":"J. Endocrinol"},{"issue":"17","key":"10.1016\/j.phrs.2004.02.004_BIB159","doi-asserted-by":"crossref","first-page":"10067","DOI":"10.1073\/pnas.1633737100","article-title":"Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability","volume":"100","author":"Grover","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.phrs.2004.02.004_BIB160","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/j.1550-8528.1995.tb00177.x","article-title":"Guidelines for the approval and use of drugs to treat obesity\u2014a position paper for the study of obesity","volume":"3","author":"Pi-Sunyer","year":"1995","journal-title":"Obes. Res"},{"key":"10.1016\/j.phrs.2004.02.004_BIB161","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2165\/00002018-200326140-00004","article-title":"A benefit-risk assessment of sibutramine in the management of obesity","volume":"26","author":"Nisoli","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/j.phrs.2004.02.004_BIB162","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1210\/me.2003-0069","article-title":"High constitutive signaling of the ghrelin receptor\u2013identification of a potent inverse agonist","volume":"17","author":"Holst","year":"2003","journal-title":"Mol. Endocrinol"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661804000490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661804000490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T07:20:40Z","timestamp":1682666440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661804000490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":162,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S1043661804000490"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2004.02.004","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}